Alzamend Neuro Inc (ALZN) vs Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

A side-by-side comparison of Alzamend Neuro Inc and Cuprina Holdings (Cayman) Limited Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alzamend Neuro Inc logo
ALZN
Alzamend Neuro Inc
$5M
$1.41HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares logo
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$6M
$2.20HealthcareDelayed quote: Oct 6, 2026, 10:01 AM EDT

Total return — ALZN vs CUPR

growth of $100 · dividends reinvested · last 1y
ALZN -79.7% (-79.7%/yr)CUPR -93.2% (-93.2%/yr)ALZN compounded faster over this window
050100150200Start $1002026$20$7
ALZN CUPR

ALZN vs CUPR: by the numbers

  • •CUPR is the larger company ($6M vs $5M market cap).
  • •Both run net losses; ALZN's is the smaller (0.00% vs -9366.75% net margin).

Metrics side by side

Valuation

MetricALZNCUPR
P/B ratio0.921.50

Profitability

MetricALZNCUPR
Gross margin0.00%-1.29%
Operating margin0.00%-9154.62%
Net margin0.00%-9366.75%
ROE-156.77%-92.44%
ROIC-156.69%-84.15%

Growth (annualized)

MetricALZNCUPR
Total return CAGR (5Y)-79.14%N/A

Go deeper

Full ALZN analysisFull CUPR analysisInteractive comparison tool

Dig into the metrics

Alzamend Neuro ROECuprina Holdings (Cayman) Limited Class A Ordinary Shares ROEAlzamend Neuro operating marginCuprina Holdings (Cayman) Limited Class A Ordinary Shares operating marginAlzamend Neuro revenue growthCuprina Holdings (Cayman) Limited Class A Ordinary Shares revenue growthAlzamend Neuro free cash flowCuprina Holdings (Cayman) Limited Class A Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.